University of Central Florida CereBank
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity of Central Florida
About this trial
Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Be 18 years or older.
Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent.
Disqualifiers
minors (under age 18).
prisoners.
pregnant women.
Trial population
Participants will donate brain tissue for research and education, aimed at improving the diagnosis and treatment of brain diseases.
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
50,000 Participants
are grouped into 1 trial groupGroup A: Donated brain tissue and biospecimens
Trial outcomes
Primary outcomes
1
Receipt of donated brain tissue and biospecimens for research and educational purposes
The UCF CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma.
Time frame
75 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov